Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: Upregulation of Bcl-xL and Mcl-1

Blood

Volumn 89, Issue 12, 1997, Pages 4415-4424

  Lømo, Jon ^a   Blomhoff, Heidi Kiil ^b   Jacobsen, Sten Eirik ^b   Krajewski, Stanislaw ^b   Reed, John C ^b   Smeland, Erlend B ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 13;

APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOID TISSUE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0030960075     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4415     Document Type: Article

References (54)

1. Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ, Greaves M: Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 179:1789, 1994
2. Cohen JJ: Programmed cell death in the immune system. Adv Immunol 50:55, 1991
3. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC: Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 72:325, 1993
4. Liu Y-J, Johnson GD, Gordon J, MacLennan ICM: Germinal centres in T-cell-dependent antibody responses. Immunol Today 13:17, 1992
5. Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB: TGFβ1 and cAMP promote apoptosis in resting human B lymphocytes. J Immunol 154:1634, 1995
6. Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF: Apoptosis in splenic B lymphocytes: Regulation by protein kinase C and IL-4. J Immunol 151:2965, 1993
7. Newell MK, VanderWall J, Beard KS, Freed JH: Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc Natl Acad Sci USA 90:10459, 1993
8. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19, 1994
9. Zurawski SM, Vega F Jr, Huyghe B, Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12:2663, 1993
10. Vita N, Lefort S, Laurent P, Caput D, Ferrara P: Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270:3512, 1995
11. Defrance T, Carayon P, Billian G, Guillemot J-C, Minty A, Caput D, Ferrara P: Interleukin 13 is a B cell stimulating factor. J Exp Med 179:135, 1994
12. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Brière F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, de Vries JE, Banchereau J, Zurawski G: Interleukin 13, a T cell-derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci USA 90:3735, 1993
13. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90:3730, 1993
14. Nilsson G, Nilsson K: Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 25:870, 1995
15. Huang S-K, Xiao H-Q, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC: IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155:2688, 1995
16. de Waal Malefyt R, Abrams JS, Zurawski SM, Lecron J-C, Mohan-Peterson S, Sanjanwala B, Bennett B, Silver J, de Vries JE, Yssel H: Differential regulation of IL-13 and IL-4 production by human CDS + and CD4+ TH0, TH1 and TH2 T cell clones and EBV-transformed B cells. Int Immunol 7:1405, 1995
17. Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O'Shea JJ, Paul WE: Similarities and differences in signal transduction by interleukin 4 and interleukin 13: Analysis of Janus kinas activation. Proc Natl Acad Sci USA 92:7681, 1995
18. Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ: Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6:267, 1994
19. Rasmussen A-M, Smeland EB, Erikstein BK, Caignault L, Funderud S: A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods 146:195, 1992
20. Swat W, Ignatowicz L, Kisielow P: Detection of apoptosis of immature CD4+8+ thymocytes by flow cytometry. J Immunol Methods 137:79, 1991
21. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7:659, 1993
22. Darzynkiewicz Z, Li X, Gong J: Assays of cell viability. Discrimination of cells dying by apoptosis, in Darzynkiewicz Z, Crissman HA, Robinson JR (eds): Methods in Cell Biology: Flow Cytometry (vol 41). San Diego, CA, Academic, 1994, p 15
23. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145:515, 1994
24. de Angelis P, Stokke T, Smedshammer L, Lothe RA, Meling GI, Rofstad M, Chen Y, Clausen OPF: p53 expression is associated with a high degree of tumor DNA aneuploidy and incidence of p53 gene mutation, and is localized to the aneuploid component in colorectal carcinomas. Int J Oncol 3:305, 1993
25. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen-driven selection in germinal centres. Nature 342:929, 1989
26. Tsubata T, Wu J, Honjo T: B cell apoptosis induced by antigen receptor crosslinking is blocked by a T cell signal through CD40. Nature 364:645, 1993
27. Cocks BG, de Waal Malefyt R, Galizzi J-P, de Vries JE, Aversa G: IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 5:657, 1993
28. Smeland EB, Beiske K, Ohlsson R, Holte H, Ruud E, Blomhoff HK, Jefferis R, Godal T: Activation of human B cells: Alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells. J Immunol 138:3179, 1987
29. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
30. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
31. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in chinese hamster ovary cells. Cancer Res 54:6348, 1994
32. Lin EY, Orlofsky A, Wang H-G, Reed JC, Prystowsky MB: A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87:983, 1996
33. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
34. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736, 1995
35. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731, 1995
36. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733, 1995
37. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G: Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921, 1995
38. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
39. Veis DJ, Sorensen CM, Shutter JR, Korsmeyer SK: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229, 1993
40. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD, Gordon J: Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 23:2368, 1993
41. Lømo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK: Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 56:40, 1996
42. Clark EA, Ledbetter JA: How B and T cells talk to each other. Nature 367:425, 1994
43. Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera P, Minty A, Vasquez A, Delfraissy J-F: Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87:1022, 1996
44. He Y-W, Malek TR: The IL-2 receptor γc chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J Immunol 155:9, 1995
45. Obiri NI, Debinski W, Leonard WJ, Puri RK: Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem 270:8797, 1995
46. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93:497, 1996
47. Grillot DAM, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, Nunez G: bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 183:381, 1996
48. Choi MSK, Holman M, Atkins CJ, Klaus GGB: Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur J Immunol 26:676, 1996
49. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res 54:5501, 1994
50. Tuscano JM, Druey KM, Riva A, Pena A, Thompson CB, Kehrl JH: Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 88:1359, 1996
51. Boise LH, Thompson CB: Hierarchical control of lymphocyte survival. Science 274:67, 1996
52. Reynolds JE, Li J, Craig RW, Eastman A: Bcl-2 and Mcl-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp Cell Res 225:430, 1996
53. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M, Reed JC: Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family function. Cell Death Diff 2:173, 1995
54. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R. Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein producion suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309, 1995